Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$51,799
+$32,148 QoQ
Shares Held
410
+190.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#2,061
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SFAM, LLC holds $1,499,211 across 9 Drug Manufacturers - General names. GILD ranks #5 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
714 | $856,393 | |
| 2 | JNJ |
Johnson & Johnson
|
902 | $229,080 | |
| 3 | ABBV |
AbbVie Inc.
|
780 | $196,279 | |
| 4 | MRK |
Merck & Co., Inc.
|
649 | $83,396 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
410 | $51,799 | |
| 6 | AMGN |
Amgen Inc
|
116 | $42,005 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
273 | $15,730 | |
| 8 | PFE |
Pfizer Inc
|
629 | $15,146 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $51,799 | 410 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $19,651 | 141 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $17,306 | 141 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||